B+
Bull case
25%
Probability
Target price
$12.00
+24.9% vs current
AVAH
Aveanna HealthcareANasdaq / Health Care Equipment & Services
Last Price
At close
2026-08-03
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$10.45
+8.7% vs current
B-
Bear case
25%
Probability
Target price
$7.50
-22.0% vs current
AI sentiment snapshot
Latest data as of 2026-07-30
Recent news sentiment (30D)
+28.0
Positive
Company
-
Unavailable
Macro
-
Unavailable
Pulse
+28.0
Positive
Sentiment proxy
+53.2
Score
AI commentary
Recent headlines were constructive around Q1 results and higher guidance, but the packet lacks a quantified post-release price reaction, analyst revision series, options data, short-interest data, employee score, and social coverage. The scheduled August 13 earnings event is the next material validation point. Unavailable fields are not treated as neutral evidence.
RankAlpha Sentiment Codex - 2026-07-30
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-13catalystQ2 2026 earnings checkpointMedium impact
Aveanna announced that it will release Q2 2026 results before the market open on August 13, 2026. No Q2 results, consensus comparison, or analyst revisions are available yet, making this a monitoring event rather than a confirmed catalyst. [#PR-EARNINGS-2026-07-23]
2026-09-30eventFamily First integration and guidance inclusionHigh impact
The company announced completion of the Family First transaction and updated FY2026 guidance to include the acquired operations. Future upside depends on integration execution and delivery against the updated outlook. [#8-K-2026-06-02]
2026-12-31catalystOrganic growth and payer-strategy executionHigh impact
Management cited Preferred Payor and Government Affairs strategies, organic growth, and execution across its national footprint as operating supports. Reimbursement, staffing, collections, and integration outcomes remain important uncertainties. [#SEC-8K-2026-05-14]
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-30 • Updated nightlySource: Internal modelMethodology